Leading proxy advisory firm iss recommends athira shareholders “withhold” support from incumbent directors joseph edelman and john fluke

New york--(business wire)--richard a. (ric) kayne, who together with his affiliates beneficially owns approximately 4.8% of the outstanding shares of common stock of athira pharma, inc. (nasdaq: atha) (“athira” or the “company”), today announced that institutional shareholder services inc. (“iss”), the nation's leading independent proxy advisory firm, has recommended that athira shareholders vote to “withhold” support for incumbent directors joseph edelman and john m. fluke jr. in connection wi
ATHA Ratings Summary
ATHA Quant Ranking